Pro-arrhythmic electrophysiological and structural remodelling in rheumatoid arthritis.

Chronic inflammatory disorders, including rheumatoid arthritis (RA), are associated with a two-fold increase in the incidence of sudden cardiac death (SCD) compared to the healthy population. Although this is partly explained by an increased prevalence of coronary artery disease, growing evidence suggests that ischaemia alone cannot completely account for the increased risk. The present review explores the mechanisms of cardiac electrophysiological remodelling in response to chronic inflammation in RA. In particular, it focuses on the roles of non-ischaemic structural remodelling, altered cardiac ionic currents and autonomic nervous system dysfunction in ventricular arrhythmogenesis and SCD. It also explores whether common genetic elements predispose to both RA and SCD. Finally, it evaluates the potential dual effects of disease-modifying therapy in both diminishing and promoting the risk of ventricular arrhythmias and SCD.

[1]  D. Judge,et al.  Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. , 2019, Circulation.

[2]  M. Boutjdir,et al.  Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression , 2019, Journal of the American Heart Association.

[3]  D. Paterson,et al.  The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies , 2019, Nature Reviews Cardiology.

[4]  G. Kitas,et al.  Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction. , 2019, International journal of cardiology.

[5]  M. Boutjdir,et al.  Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation , 2018, PloS one.

[6]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[7]  M. Nahrendorf,et al.  Cardioimmunology: the immune system in cardiac homeostasis and disease , 2018, Nature Reviews Immunology.

[8]  M. Takei,et al.  Heart Rate–corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab , 2018, The Journal of Rheumatology.

[9]  M. Ciccarelli,et al.  Cardiac eccentric remodeling in patients with rheumatoid arthritis , 2018, Scientific Reports.

[10]  P. Camelliti,et al.  Role of Non-Myocyte Gap Junctions and Connexin Hemichannels in Cardiovascular Health and Disease: Novel Therapeutic Targets? , 2018, International journal of molecular sciences.

[11]  Monica Salerno,et al.  Heart rate variability as predictive factor for sudden cardiac death , 2018, Aging.

[12]  M. Huber-Lang,et al.  Experimental blunt chest trauma-induced myocardial inflammation and alteration of gap-junction protein connexin 43 , 2017, PloS one.

[13]  M. Takei,et al.  Magnetic Resonance Imaging–Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N‐Terminal Pro–Brain Natriuretic Peptide Levels , 2017, Arthritis care & research.

[14]  Phang Boon Lim,et al.  Sudden cardiac death in patients with rheumatoid arthritis , 2017, World journal of cardiology.

[15]  R. D. de Boer,et al.  From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities , 2017, Current Heart Failure Reports.

[16]  K. Shivkumar,et al.  Brugada syndrome—Malignant phenotype associated with acute cardiac inflammation? , 2017, HeartRhythm case reports.

[17]  P. Tak,et al.  Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis , 2017, Journal of internal medicine.

[18]  M. Boutjdir,et al.  Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes , 2017, Heart.

[19]  Andrej J. Savol,et al.  Macrophages Facilitate Electrical Conduction in the Heart , 2017, Cell.

[20]  S. Singla,et al.  Prevalence of Autonomic Neuropathy in Patients of Rheumatoid Arthritis and Its Correlation with Disease Severity. , 2017, Journal of clinical and diagnostic research : JCDR.

[21]  G. Firestein,et al.  Immunopathogenesis of Rheumatoid Arthritis. , 2017, Immunity.

[22]  Hong Zhang,et al.  Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats , 2016, BMC Musculoskeletal Disorders.

[23]  B. Yan,et al.  Electrophysiological mechanisms of long and short QT syndromes , 2016, International journal of cardiology. Heart & vasculature.

[24]  Rosana A Bassani,et al.  Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice , 2016, Nature Communications.

[25]  Javier Martín,et al.  Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. , 2016, Autoimmunity reviews.

[26]  G. Lip,et al.  Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis , 2016, The Journal of physiology.

[27]  M. Boutjdir,et al.  Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis , 2016, Front. Cardiovasc. Med..

[28]  M. Maes,et al.  Connexins and their channels in inflammation , 2016, Critical reviews in biochemistry and molecular biology.

[29]  P. Lazzerini,et al.  Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis , 2016, European heart journal.

[30]  M. Boutjdir,et al.  Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes , 2016, Circulation. Arrhythmia and electrophysiology.

[31]  X. Tu,et al.  Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells , 2016, BMC Cardiovascular Disorders.

[32]  T. Jernberg,et al.  Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. , 2015, European heart journal.

[33]  C. January,et al.  Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome , 2015, Circulation.

[34]  P. Lazzerini,et al.  Long QT Syndrome: An Emerging Role for Inflammation and Immunity , 2015, Front. Cardiovasc. Med..

[35]  W. Yuan,et al.  Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes. , 2015, American journal of translational research.

[36]  P. Matthews,et al.  Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.

[37]  G. Kitas,et al.  Association Between Corrected QT Interval and Inflammatory Cytokines in Rheumatoid Arthritis , 2015, The Journal of Rheumatology.

[38]  P. Lazzerini,et al.  Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation , 2015, Arthritis care & research.

[39]  P. Libby,et al.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. , 2015, European heart journal.

[40]  N. Sattar,et al.  An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy , 2015, Arthritis & rheumatology.

[41]  W. Gulliver,et al.  The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis , 2015, Annals of the rheumatic diseases.

[42]  George D Kitas,et al.  Autonomic function and rheumatoid arthritis: a systematic review. , 2014, Seminars in arthritis and rheumatism.

[43]  H. Karagueuzian,et al.  Cardiac fibrosis as a determinant of ventricular tachyarrhythmias , 2014, Journal of arrhythmia.

[44]  P. Lazzerini,et al.  Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. , 2014, Autoimmunity reviews.

[45]  M. Zile,et al.  Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy. , 2014, American journal of physiology. Heart and circulatory physiology.

[46]  Rahul Jain,et al.  Fragmented ECG as a Risk Marker in Cardiovascular Diseases , 2014, Current cardiology reviews.

[47]  M. Wahren-Herlenius,et al.  Molecular mechanisms of congenital heart block. , 2014, Experimental cell research.

[48]  C. Fiset,et al.  Interleukin-1β Reduces L-type Ca2+ Current through Protein Kinase Cϵ Activation in Mouse Heart* , 2014, The Journal of Biological Chemistry.

[49]  L. Klein,et al.  Sudden cardiac death in heart failure. , 2014, Cardiology clinics.

[50]  M. Jiang,et al.  [Ca2+]i Elevation and Oxidative Stress Induce KCNQ1 Protein Translocation from the Cytosol to the Cell Surface and Increase Slow Delayed Rectifier (IKs) in Cardiac Myocytes* , 2013, The Journal of Biological Chemistry.

[51]  F. Charpentier,et al.  Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death , 2013, Front. Physiol..

[52]  M. Budoff,et al.  Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease , 2013, Annals of the rheumatic diseases.

[53]  P. Lazzerini,et al.  Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. , 2013, European journal of internal medicine.

[54]  T. Therneau,et al.  Longterm Outcomes and Treatment After Myocardial Infarction in Patients with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.

[55]  T. Glant,et al.  Genetics of Rheumatoid Arthritis — A Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.

[56]  S. Banik,et al.  Pharmacotherapy Options in Rheumatoid Arthritis , 2013, Clinical medicine insights. Arthritis and musculoskeletal disorders.

[57]  K. Deepak,et al.  A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis , 2012, The Indian journal of medical research.

[58]  D. Rosenbaum,et al.  Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. , 2012, Journal of the American College of Cardiology.

[59]  A. Çelik,et al.  Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study , 2012, Modern rheumatology.

[60]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[61]  G. Eisenhofer,et al.  Autonomic Nervous System Function in Rheumatoid Arthritis , 2012, Cellular and molecular neurobiology.

[62]  Candido Cabo,et al.  Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. , 2012, American journal of physiology. Heart and circulatory physiology.

[63]  H. Evrengul,et al.  Effect of Infliximab Treatment on QT Intervals in Patients With Ankylosing Spondylitis , 2011, Journal of Investigative Medicine.

[64]  P. Lazzerini,et al.  Anti‐Ro/SSA–associated corrected QT interval prolongation in adults: The role of antibody level and specificity , 2011, Arthritis care & research.

[65]  A. Pfeufer,et al.  Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. , 2011, Deutsches Arzteblatt international.

[66]  Jacques M. T. de Bakker,et al.  Fibrosis and Cardiac Arrhythmias , 2011 .

[67]  Y. Liao,et al.  Effect of Tumor Necrosis Factor-α on Neutralization of Ventricular Fibrillation in Rats with Acute Myocardial Infarction , 2011, Mediators of inflammation.

[68]  K. Yodogawa,et al.  Effect of Corticosteroid Therapy on Ventricular Arrhythmias in Patients with Cardiac Sarcoidosis , 2011, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[69]  C. Çevik,et al.  Fragmented QRS Complexes Are Associated with Cardiac Fibrosis and Significant Intraventricular Systolic Dyssynchrony in Nonischemic Dilated Cardiomyopathy Patients with a Narrow QRS Interval , 2011, Echocardiography.

[70]  J. Lima,et al.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study , 2010, Arthritis research & therapy.

[71]  S. Harrison,et al.  TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes , 2010, Cell calcium.

[72]  E. Terzioğlu,et al.  Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus , 2010, Lupus.

[73]  U. Eriksson,et al.  Mechanisms of cardiac fibrosis in inflammatory heart disease. , 2009, Trends in cardiovascular medicine.

[74]  U. Eriksson,et al.  Heart-Infiltrating Prominin-1+/CD133+ Progenitor Cells Represent the Cellular Source of Transforming Growth Factor &bgr;–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis , 2009, Circulation research.

[75]  S. Grandy,et al.  Ventricular K+ currents are reduced in mice with elevated levels of serum TNFalpha. , 2009, Journal of molecular and cellular cardiology.

[76]  R. Gallucci,et al.  Interleukin (IL)‐6 modulates transforming growth factor‐β expression in skin and dermal fibroblasts from IL‐6‐deficient mice , 2009, The British journal of dermatology.

[77]  H. Kestler,et al.  Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy , 2009, European heart journal.

[78]  P. Lazzerini,et al.  Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. , 2008, The Journal of rheumatology.

[79]  H. John,et al.  Hypertension in rheumatoid arthritis. , 2008, Rheumatology.

[80]  J. Armitage,et al.  Acute coronary syndromes complicating the first infusion of rituximab. , 2008, Clinical lymphoma & myeloma.

[81]  Takahiko Horiuchi,et al.  Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. , 2008, Arthritis and rheumatism.

[82]  Marmar Vaseghi,et al.  The role of the autonomic nervous system in sudden cardiac death. , 2008, Progress in cardiovascular diseases.

[83]  Peter Nightingale,et al.  Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[84]  G. Citera,et al.  Clinical significance of anti-Ro antibodies in rheumatoid arthritis , 2008, Clinical Rheumatology.

[85]  T. Hirano,et al.  SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes. , 2007, Journal of molecular and cellular cardiology.

[86]  H. Morita,et al.  Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome. , 2007, Journal of the American College of Cardiology.

[87]  M. Borggrefe,et al.  Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study. , 2007, Cytokine.

[88]  K. Wahbi,et al.  Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. , 2007, The Journal of rheumatology.

[89]  A. Silman,et al.  Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register , 2007, Arthritis and rheumatism.

[90]  N. Shostak,et al.  Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients , 2007, International journal of clinical practice.

[91]  M. Duru,et al.  P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters , 2007, Rheumatology International.

[92]  O. Hurtado,et al.  TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. , 2007, American journal of physiology. Heart and circulatory physiology.

[93]  R. Price,et al.  Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. , 2007, American journal of physiology. Heart and circulatory physiology.

[94]  W. Ollier,et al.  HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[95]  C. Long,et al.  IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. , 2007, American journal of physiology. Heart and circulatory physiology.

[96]  P. Seferovic,et al.  Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. , 2006, Rheumatology.

[97]  C. Brand,et al.  Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[98]  Gani Bajraktari,et al.  Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease , 2006, International journal of clinical practice.

[99]  M. Horie,et al.  Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the asphingomyelin pathway. , 2006, Biochemical and biophysical research communications.

[100]  K. Kawahara,et al.  Tumor Necrosis Factor-α Downregulates the Voltage Gated Outward K+ Current in Cultured Neonatal Rat Cardiomyocytes , 2006 .

[101]  G. Salama,et al.  Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. , 2006, American journal of physiology. Heart and circulatory physiology.

[102]  Ş. Arslan,et al.  Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease , 2006, Clinical Rheumatology.

[103]  G. Lip,et al.  Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? , 2006, Journal of the American College of Cardiology.

[104]  M. Lapeyre-Mestre,et al.  [Cardiac effects of cytokines produced after rituximab infusion]. , 2005, Bulletin du cancer.

[105]  B. Greenberg,et al.  Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts. , 2005, American journal of physiology. Heart and circulatory physiology.

[106]  J. Lecron,et al.  Role of interleukin‐6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation , 2005, Journal of cellular physiology.

[107]  N. Goodson,et al.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s , 2005, Annals of the rheumatic diseases.

[108]  G. Kitas,et al.  Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[109]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[110]  D. Kem,et al.  Tumor Necrosis Factor α, Rapid Ventricular Tachyarrhythmias, and Infarct Size in Canine Models of Myocardial Infarction , 2005, Journal of cardiovascular pharmacology.

[111]  S. Gabriel,et al.  Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. , 2005, Arthritis and rheumatism.

[112]  S. Ball,et al.  Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. , 2004, Cardiovascular research.

[113]  A. Gnasso,et al.  Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. , 2004, Atherosclerosis.

[114]  B. Polat,et al.  Heart rate variability in patients with rheumatoid arthritis , 2004, Rheumatology International.

[115]  Hui-zhen Wang,et al.  Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-α , 2004, Journal of Biological Chemistry.

[116]  P. Lazzerini,et al.  Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. , 2004, Arthritis and rheumatism.

[117]  R. Wojtala,et al.  The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis , 2004, Clinical Rheumatology.

[118]  W. Ollier,et al.  Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. , 2004, Seminars in arthritis and rheumatism.

[119]  M. Braun,et al.  Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist , 2003, Annals of Internal Medicine.

[120]  J. Francis,et al.  Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[121]  R. Maestri,et al.  Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.

[122]  V. Shusterman,et al.  Calcium-dependent arrhythmias in transgenic mice with heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.

[123]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[124]  A. Silman,et al.  The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. , 2002, Rheumatology.

[125]  A. Silman,et al.  Epidemiology and genetics of rheumatoid arthritis , 2002, Arthritis research.

[126]  H. Jongsma,et al.  Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. , 2002, Cardiovascular research.

[127]  A. Cindaş,et al.  QT dispersion and cardiac involvement in patients with rheumatoid arthritis , 2002, Scandinavian Journal of Rheumatology.

[128]  D. Mann,et al.  Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor , 2001, Circulation.

[129]  M. Boutjdir,et al.  Down‐regulation of L‐type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[130]  M. Boutjdir,et al.  Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. , 2001, Journal of molecular and cellular cardiology.

[131]  S. Maier,et al.  Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats , 2000, Autonomic Neuroscience.

[132]  V. Diehl,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8) , 2016 .

[133]  K. A. Yamada,et al.  Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. , 1999, Cardiovascular research.

[134]  A. Maio,et al.  Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. , 1999, Cytokine.

[135]  B. Komşuoğlu,et al.  Dispersion of ventricular repolarization: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. , 1998, The Journal of rheumatology.

[136]  D. Vergani,et al.  Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures , 1997, Clinical and experimental immunology.

[137]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[138]  K M Kessler,et al.  Frequency of sudden cardiac death and profiles of risk. , 1997, The American journal of cardiology.

[139]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[140]  Steven F. Maier,et al.  Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.

[141]  G. Rozanski,et al.  Interleukin-1 enhances beta-responsiveness of cardiac L-type calcium current suppressed by acidosis. , 1994, American Journal of Physiology.

[142]  Y. -. Li,et al.  Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells. , 1993, Cardiovascular research.

[143]  Y. Oomura,et al.  The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. , 1991, Journal of the autonomic nervous system.

[144]  F. Bianchi,et al.  Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. , 1983, Clinical and experimental immunology.

[145]  E. Atwater,et al.  Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study and review. , 1969, Archives of internal medicine.

[146]  P. Bennett,et al.  Autonomic Neuropathy in Rheumatoid Arthritis , 1965, Annals of the rheumatic diseases.

[147]  B. Cruickshank Heart lesions in rheumatoid disease. , 1958, The Journal of pathology and bacteriology.

[148]  Xiuhua Wang,et al.  Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63–Integrin &bgr;1 Interaction , 2017, Hypertension.

[149]  M. Lindsey,et al.  Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation. , 2015, Heart rhythm.

[150]  P. Krishan,et al.  Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis. , 2015, Acta reumatologica portuguesa.

[151]  Özcan Özgür Ulaș,et al.  Ventricular arrhythmia with cessation of infliximab in a patient with ankylosing spondylitis , 2015 .

[152]  S. Gabriel,et al.  Population-based study of QT interval prolongation in patients with rheumatoid arthritis. , 2015, Clinical and experimental rheumatology.

[153]  G. Kitas,et al.  Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. , 2014, Rheumatology.

[154]  K. Midwood,et al.  Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. , 2012, Rheumatology.

[155]  R. Cattaneo,et al.  Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. , 2006, Clinical and experimental rheumatology.

[156]  C. Tovar,et al.  c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[157]  E. Kentala,et al.  Electrocardiographic findings in patients with connective tissue disease. , 1978, Scandinavian journal of rheumatology.